An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to explore the efficacy of Nasonex (mometasone furoate
nasal spray) in comparison with placebo in improving the quality of life of subjects with
moderate to severe persistent allergic rhinitis and intermittent asthma. A secondary
objective is to evaluate the efficacy of Nasonex in relieving the subject's symptoms of
allergic rhinitis and asthma.